Cargando…

Gut Microbiota and Immunotherapy

The gut microbiota is the largest microbiota in the body, which is closely related to the immune state of the body. A number of studies have shown that gut microbiota and its metabolites are involved in host immune regulation. Immune checkpoint inhibitors have become an important drug for the treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaoqing, Ying, Jieer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283110/
https://www.ncbi.nlm.nih.gov/pubmed/35847121
http://dx.doi.org/10.3389/fmicb.2022.945887
_version_ 1784747263643353088
author Xu, Xiaoqing
Ying, Jieer
author_facet Xu, Xiaoqing
Ying, Jieer
author_sort Xu, Xiaoqing
collection PubMed
description The gut microbiota is the largest microbiota in the body, which is closely related to the immune state of the body. A number of studies have shown that gut microbiota and its metabolites are involved in host immune regulation. Immune checkpoint inhibitors have become an important drug for the treatment of many malignant tumors, which can significantly improve the prognosis of tumor patients. However, a considerable number of patients cannot benefit from immune checkpoint inhibitors. At present, the known treatment methods of microbiota manipulation mainly include fecal microbiota transplantation, dietary regulation, prebiotics and so on. Therefore, this paper will discuss the possibility of improving the anti-tumor efficacy of immunotherapy from the perspectives of the gut microbiota and immunotherapy.
format Online
Article
Text
id pubmed-9283110
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92831102022-07-16 Gut Microbiota and Immunotherapy Xu, Xiaoqing Ying, Jieer Front Microbiol Microbiology The gut microbiota is the largest microbiota in the body, which is closely related to the immune state of the body. A number of studies have shown that gut microbiota and its metabolites are involved in host immune regulation. Immune checkpoint inhibitors have become an important drug for the treatment of many malignant tumors, which can significantly improve the prognosis of tumor patients. However, a considerable number of patients cannot benefit from immune checkpoint inhibitors. At present, the known treatment methods of microbiota manipulation mainly include fecal microbiota transplantation, dietary regulation, prebiotics and so on. Therefore, this paper will discuss the possibility of improving the anti-tumor efficacy of immunotherapy from the perspectives of the gut microbiota and immunotherapy. Frontiers Media S.A. 2022-07-01 /pmc/articles/PMC9283110/ /pubmed/35847121 http://dx.doi.org/10.3389/fmicb.2022.945887 Text en Copyright © 2022 Xu and Ying. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Xu, Xiaoqing
Ying, Jieer
Gut Microbiota and Immunotherapy
title Gut Microbiota and Immunotherapy
title_full Gut Microbiota and Immunotherapy
title_fullStr Gut Microbiota and Immunotherapy
title_full_unstemmed Gut Microbiota and Immunotherapy
title_short Gut Microbiota and Immunotherapy
title_sort gut microbiota and immunotherapy
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283110/
https://www.ncbi.nlm.nih.gov/pubmed/35847121
http://dx.doi.org/10.3389/fmicb.2022.945887
work_keys_str_mv AT xuxiaoqing gutmicrobiotaandimmunotherapy
AT yingjieer gutmicrobiotaandimmunotherapy